Provider of behavioral change programs AbilTo has closed a $12 million Series C round of financing, with plans to use the fresh capital to accelerate the deployment of engagement, care delivery and infrastructure capabilities.
HLM Venture Partners (HLM) led the round, and Yumin Choi, Partner at HLM, has joined the company’s board of directors. Previous investors BlueCross BlueShield Venture Partners, .406 Ventures and Sandbox Industries also participated in the financing.
“HLM has been closely following the space for some time. AbilTo is recognized as the leader in the field of remote behavioral health,” said Choi. “The company has already achieved national scale, best-in-class engagement rates and proven clinical results; it is poised for enormous growth in the coming months.”
Founded in 2008, AbilTo leverages emerging technology to deliver proven behavioral change therapy for the benefit of large medical populations, including cardiac patients, new mothers and those suffering from diabetes, as well as individuals suffering from depression/anxiety and chronic pain. The company offers 16 programs that are delivered by telephone or the Internet.
Earlier this year, AbilTo and Aetna co-authored an article in The American Journal of Managed Care (AJMC) showing substantial reductions in re-hospitalization rates among heart patients graduating from AbilTo’s cardiac program.